Radio(chemo)therapy in locally advanced nonsmall cell lung cancer.

Glatzer, Markus; Eliçin, Olgun; Ramella, Sara; Nestle, Ursula; Putora, Paul Martin (2016). Radio(chemo)therapy in locally advanced nonsmall cell lung cancer. European respiratory review, 25(139), pp. 65-70. European Respiratory Society 10.1183/16000617.0053-2015

[img]
Preview
Text
65.full.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (246kB) | Preview

Definitive radiochemotherapy is the standard treatment for many patients with locally advanced nonsmall cell lung cancer (NSCLC). Treatment outcomes have improved over the last decades. Several treatment regimens have been shown effective and safe. This review summarises the results of significant studies between 1996 and 2015 on concomitant and sequential radiochemotherapy regimens and radiation dose per fraction. Beside therapy regimens, optimised radiotherapy planning is indispensable to improve outcome and minimise radiation-induced toxicity. An insight into the rationale of radiotherapy planning for stage III NSCLC is also provided.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Glatzer, Markus; Eliçin, Olgun and Putora, Paul Martin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0905-9180

Publisher:

European Respiratory Society

Language:

English

Submitter:

Beatrice Scheidegger

Date Deposited:

11 Apr 2017 10:04

Last Modified:

11 Apr 2017 10:04

Publisher DOI:

10.1183/16000617.0053-2015

PubMed ID:

26929423

BORIS DOI:

10.7892/boris.92824

URI:

https://boris.unibe.ch/id/eprint/92824

Actions (login required)

Edit item Edit item
Provide Feedback